ArticleViruses2023

Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV.

Carlos Dueñas-Gutiérrez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.